Director/PDMR Shareholding

RNS Number : 7043U

GlaxoSmithKline PLC

02 January 2013

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.43 per Ordinary Share, and notional ADSs at a price of $43.39 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2012 to 31 December 2012:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,513.031
Professor Sir Roy Anderson	628.258
Dr Stephanie Burns		339.609
Stacey Cartwright	349.032
Sir Crispin Davis	2,326.880
Lynn  Elsenhans		611.296
Judy Lewent	169.804
Sir Deryck Maughan	679.218
Dr Daniel Podolsky	713.178
Tom de Swaan	860.946
Jing Ulrich		237.726
Sir Robert Wilson	628.258

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2013.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 January 2013

 

END

 

 

RDSQLLFBXFFXBBL